Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...
Best TENS machines for effective chronic pain relief
Best TENS machines for effective chronic pain relief - Discover the benefits and drawbacks of using electrical nerve ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Beyond Period Pain: Adolescent Endometriosis And The Fight Against Chronic Pain
Adolescent endometriosis causes girls to live in chronic pain and miss classes; There is potential for better health outcomes with comprehensive treatment.
BioPharma Dive8h
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
India Today on MSN3h
Vertex: New non-opioid painkiller Journavx approved by FDA
The FDA approved Vertex Pharmaceuticals' Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
StyleBlueprint10h
5 Holistic Treatments to Try in BHAM to Feel Your Best
Whether you want to relieve pain, reduce stress, or promote holistic well-being, these are some of the best alternative ...
Ryoncil® Commercial Launch Update And Product Pipeline
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress of the U.S. commercial launch of Ryoncil ® ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...